MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Q2 2023 Filing
Filed August 9, 2023
Portfolio Value
$304.6B
Holdings
821
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (821 positions)
| Stock | Value |
|---|---|
ATLCATLANTICUS HOLDINGS CORP | $323K |
GBYSANGAMO THERAPEUTICS INC | $268K |
KRKROGER CO | $266K |
TMHCTAYLOR MORRISON HOME CORP | $265K |
NTNXNUTANIX INC | $254K |
TAT&T INC | $250K |
MEDMEDIFAST INC | $244K |
ESGEISHARES INC | $233K |
BMYBRISTOL-MYERS SQUIBB CO | $225K |
VGREURVECTOR GROUP LTD | $213K |
NRIXNURIX THERAPEUTICS INC | $208K |
OTXOPEN TEXT CORP | $206K |
CMCANADIAN IMPERIAL BK COMM TO | $204K |
EBSEMERGENT BIOSOLUTIONS INC | $198K |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $186K |
BVSBIOVENTUS INC | $171K |
FATEFATE THERAPEUTICS INC | $164K |
YMABUSDY-MABS THERAPEUTICS INC | $156K |
ALECALECTOR INC | $137K |
TWOU2U INC | $124K |
FGENEURFIBROGEN INC | $63K |
PreviousPage 9 of 9